- Home
- ICMB vs LTRN Comparison
ICMB vs LTRN Comparison
Compare ICMB & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICMB | LTRN |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.8M | 38.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ICMB | LTRN |
|---|---|---|
| Price | $2.78 | $3.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 23.4K | ★ 56.2K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | ★ 18.74% | N/A |
| EPS Growth | ★ 31.51 | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $17,931,778.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.75 | N/A |
| P/E Ratio | $7.24 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.46 | $2.55 |
| 52 Week High | $3.47 | $6.12 |
Technical Indicators
Market Signals| Indicator | ICMB | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 50.91 |
| Support Level | $2.75 | $3.32 |
| Resistance Level | $2.89 | $3.56 |
| Average True Range (ATR) | 0.06 | 0.20 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 65.00 | 73.47 |
Price Performance
Historical ComparisonAbout ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.